15 women with therapy-resistant OAB will be included. All patients must be qualified for conventional cystoscopic Botox injection. The study is not randomized or blinded. Follow-up time is six months with voiding charts and three questionnaires.(UDI-6, IIQ-7, ICIQ-UI SF) as well as a satisfaction with treatment VAS.